Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Details)

v3.20.2
Interim Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment information            
Revenue $ 8,320   $ 7,569   $ 15,670 $ 16,571
Cost of revenue 5,529   5,990   10,037 11,746
Gross profit $ 2,791   $ 1,579   $ 5,633 $ 4,825
Gross margin 33.50%   20.90%   35.90% 29.10%
Research and development $ 914   $ 1,449   $ 1,859 $ 3,005
Segment Profit Loss 1,877   130   3,774 1,820
Operating expenses            
Sales and marketing 1,448   2,259   2,824 4,591
General and administrative 1,102   1,249   2,312 2,613
Intangible amortization 225   308   451 616
Operating profit (loss) (898)   (3,686)   (1,813) (6,000)
Other Nonoperating Income (Expense) 15   125   45 289
Income tax benefit (expense) (2)   0   58 (7)
Net income (loss) (885) [1] $ (825) (3,561) [1] $ (2,157) (1,710) [1] (5,718) [1]
IBW [Member]            
Segment information            
Revenue 3,021   2,618   5,970 5,541
Cost of revenue 1,987   2,205   3,736 4,156
Gross profit $ 1,034   $ 413   $ 2,234 $ 1,385
Gross margin 34.20%   15.80%   37.40% 25.00%
Research and development $ 315   $ 403   $ 664 $ 802
Segment Profit Loss 719   10   1,570 583
ISM [Member]            
Segment information            
Revenue 1,908   2,646   3,955 5,741
Cost of revenue 883   1,604   1,775 3,120
Gross profit $ 1,025   $ 1,042   $ 2,180 $ 2,621
Gross margin 53.70%   39.40%   55.10% 45.70%
Research and development $ 404   $ 619   $ 786 $ 1,320
Segment Profit Loss 621   423   1,394 1,301
CNS [Member]            
Segment information            
Revenue 3,391   2,305   5,745 5,289
Cost of revenue 2,659   2,181   4,526 4,470
Gross profit $ 732   $ 124   $ 1,219 $ 819
Gross margin 21.60%   5.40%   21.20% 15.50%
Research and development $ 195   $ 427   $ 409 $ 883
Segment Profit Loss $ 537   $ (303)   $ 810 $ (64)
[1] Net income (loss) and comprehensive income (loss) are the same for the periods reported.